Company / Capital Returned to Shareholders
LeMaitre Vascular Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$19.9M
FY2025
5-year range
$7.4M / $19.9M
FY2021-FY2025
Trend
+23.8%
vs FY2024
Sector context
#82 of 108
Health Care
What the data says
LeMaitre Vascular's capital returned to shareholders of $20M is lower than 76% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders has increased for 8 consecutive years, from $3M in FY2017 to $20M in FY2025.
Based on SEC 10-K filings.
$20M in FY2025 with a 5-year CAGR of +26.4%.
Improved from $13M to $20M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +34.1%
- 5-Year CAGR
- +26.4%
- 10-Year CAGR
- -
Sector benchmark
-97.3% below sector average
Key checks
Key Insights
- LeMaitre Vascular's capital returned to shareholders has grown for 8 consecutive years.
- 5-year CAGR of +26.4%, indicating consistent growth.
- In FY2025, capital returned to shareholders increased 23.8% year-over-year.
- Ranks #82 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.9M | +23.8% |
| FY2024 | $16.1M | +21.0% |
| FY2023 | $13.3M | +60.9% |
| FY2022 | $8.3M | +11.4% |
| FY2021 | $7.4M | +19.9% |
| FY2020 | $6.2M | +24.8% |
| FY2019 | $5.0M | +36.4% |
| FY2018 | $3.6M | +16.8% |
| FY2017 | $3.1M | -14.4% |
| FY2016 | $3.6M | +64.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026